Wagle Shukla et al., 2017) (Table 1)
Proton pump inhibitors reduce gastric acid production, which impairs the release of food-bound B12 but has less effect on synthetic B12 in supplements
Beyond these hematopoietic agents, more targeted approaches aim to modulate cytokine cascades and immune checkpoints (Fig
This randomized phase 2a #ClinicalTrial demonstrates that TPN171H, a potent and selective PDE5 inhibitor, significantly reduces pulmonary vascular resistance and improves acute hemodynamics in patients with #PulmonaryArterialHypertension (PAH), establishing it as a promising and well-tolerated oral therapeutic candidate for managing PAH
The enzymatic properties and substrate preferences of TGR, they found, differed somewhat from those of its mammalian counterparts
Participant selection will be based on the inclusion and exclusion criteria described below